Ryan Svoboda to Skin Neoplasms
This is a "connection" page, showing publications Ryan Svoboda has written about Skin Neoplasms.
Connection Strength
2.241
-
Svoboda RM, Glazer AM, Farberg AS, Cowdrey MCE, Rigel DS. Melanoma Reporting Practices of United States Dermatologists. Dermatol Surg. 2018 11; 44(11):1391-1395.
Score: 0.422
-
Svoboda RM, Prado G, Mirsky RS, Rigel DS. Assessment of clinician accuracy for diagnosing melanoma on the basis of electrical impedance spectroscopy score plus morphology versus lesion morphology alone. J Am Acad Dermatol. 2019 Jan; 80(1):285-287.
Score: 0.418
-
Svoboda RM, Glazer AM, Farberg AS, Rigel DS. Factors Affecting Dermatologists' Use of a 31-Gene Expression Profiling Test as an Adjunct for Predicting Metastatic Risk in Cutaneous Melanoma. J Drugs Dermatol. 2018 May 01; 17(5):544-547.
Score: 0.407
-
Svoboda RM, Gharia MJ, Shell J, Gregory WD. Bioimpedance measurement as an assessment of margin positivity in Mohs surgical specimens of nonmelanoma skin cancer: Management implications. J Am Acad Dermatol. 2018 Sep; 79(3):591-593.
Score: 0.404
-
Svoboda RM, Mackay D, Welsch MJ, Anderson BE. Multiple cutaneous metastatic chordomas from the sacrum. J Am Acad Dermatol. 2012 Jun; 66(6):e246-7.
Score: 0.270
-
Prado G, Ederle AE, Shahriari SRK, Svoboda RM, Farberg AS, Rigel DS. Online sunscreen purchases: Impact of product characteristics and marketing claims. Photodermatol Photoimmunol Photomed. 2019 Sep; 35(5):339-343.
Score: 0.110
-
Mirsky R, Prado G, Svoboda R, Glazer A, Rigel D. Management Decisions Made by Physician Assistants and Nurse Practitioners in Cutaneous Malignant Melanoma Patients: Impact of a 31-Gene Expression Profile Test J Drugs Dermatol. 2018 11 01; 17(11):1220-1223.
Score: 0.105
-
Svoboda RM, Friedman RJ, Rigel DS. Skin Self-examination for Skin Cancer Prevention. JAMA. 2018 08 21; 320(7):720-721.
Score: 0.104